Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus. - Wikidata - awgldk - TriplyDB

Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.

Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.

http://www.wikidata.org/entity/Q34173972

about

Current management and future directions in the treatment of advanced renal cell carcinoma-a latin american perspective: 10 years in review Subverting the B7-H1/PD-1 pathway in advanced melanoma and kidney cancer High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model Understanding, recognizing, and managing toxicities of targeted anticancer therapies.Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan.Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma Alleviating neurodegeneration in Drosophila models of PolyQ diseases.Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes.Current treatment considerations in metastatic renal cell carcinoma.Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma.Temsirolimus: a safety and efficacy review.Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.Current status of DILD in molecular targeted therapies.Adverse events associated with mTOR inhibitors.Everolimus: side effect profile and management of toxicities in breast cancer.Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies.mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions.Safety of mTOR inhibitors in adult solid organ transplantation.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges.Interstitial lung disease induced by alectinib (CH5424802/RO5424802).PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.mTOR inhibitor-related pulmonary toxicity; incidence even higher.Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.

P2860

Q26774515-01026DE4-F7ED-4CEA-9D4E-B1E3EF5287AB Q26852704-A0CF1504-0701-44EE-9F6B-EF4FD62EE902 Q27323092-E45D85F7-33C7-4706-A568-B3E65AE8D41C Q33408049-DA3A1C13-999D-4B4A-BA2A-47D33A7046B3 Q33410008-CA6F6507-8CF2-4201-968E-31BBF1311A1B Q33410223-1B7293ED-6147-40C8-90AC-561DBF34E408 Q34775380-BDE107A0-F4DC-4044-B983-8137F1F53DA2 Q35051496-E6C151A1-C36F-4DFB-AEBC-2419716E0ED2 Q35051964-E09E3BD5-6553-46A2-A131-BFFB0DAF2FD9 Q35797388-26B3D6D1-9C3A-4768-BC8E-4701A651C0AC Q36003663-34B2A375-204C-4F1A-9EDC-D7C23F781915 Q36064933-523016FC-C5B4-4EF7-A92B-46835B003DF4 Q36318627-339EEB49-6757-44C7-B149-88CE62B1573A Q36494977-52CAACDD-2C0E-4775-B299-3148BA51344F Q37495852-49F01D3A-63BC-4A82-924C-BD83217A64A1 Q37589551-80676BC4-0499-43DD-94B2-6FCF89B13D6A Q37621799-D4CE1D3B-2A68-4783-BA69-B7A100039539 Q37992827-1087CF15-E1FD-41DE-86A5-2276F962A8AB Q38028411-F29E3FE3-9410-4701-B4FD-4F8909FA03E2 Q38031941-577DFC5E-6E60-48DA-9F63-FF2057CB13B6 Q38058679-68DE6BD6-40D4-48A9-9C71-A8EC11EF1F8A Q38059819-682D9A8C-CC90-4B6B-B294-CA9E7B4704EB Q38068519-D4A4A93C-9F08-4DCA-85C0-25235561679C Q38125944-D1645879-F99A-4F48-B064-A5E60CE64C2A Q38187149-12D96D36-FB6C-4991-A103-16E0CF52AB32 Q38258712-52E4F94B-2D41-43A6-96C8-3C2F45B74A71 Q38603164-8B9C2014-107E-4C9E-8273-5407FF0C104A Q38647604-C849FFDB-47F2-4BF4-86EC-C6B774458252 Q38669190-85342353-8836-4C6A-AC46-C8030510C76E Q38962103-64E23030-67C9-4279-A0F4-877843793C1A Q39096266-16B2B29A-8D5A-42E8-A59D-FF57C53EB410 Q41660655-D7BE3DA2-F373-43A3-AD2D-99826CB0522A Q46320590-3B4E8231-0C63-440A-BD9F-8DA10871E204 Q46952013-8FE324C5-75BA-4376-B6A5-D0CC0E87491F Q50133191-96EB5E9B-E372-4F40-93D2-5DF262F45CC4 Q53706060-11544286-A3E1-408E-B95C-6F6F72F83C9C

P2860

Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.

http://www.wikidata.org/entity/Q34173972

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@ast

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@en

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@nl

type

label

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@ast

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@en

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@nl

prefLabel

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@ast

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@en

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@nl

P1433

Q34173972-E46E9E71-6991-46D5-AFB3-56CADFF2FC58

P1476

Q34173972-740B1215-109B-4104-B78A-5D0A042E884F

P2093

Q34173972-0D440809-5D40-40E5-9CFE-05FA62F82329

Q34173972-197CCC5B-BE5C-4B51-8413-0E3B9CB2AFAD

Q34173972-2C17E435-69CC-4A4B-83ED-C1D0DFC0D4BD

Q34173972-42747F23-0BBA-4593-BB7D-C56532B745D3

Q34173972-653762D5-3F5B-481E-880D-01E5E39E9E3E

Q34173972-941AA73A-2880-4F73-98D8-A0727BD16D00

Q34173972-D8064460-479C-4A53-BF59-53B37D6C026E

Q34173972-E5EEE506-5207-442D-A6E1-F4830DA8B23C

Q34173972-E835491C-6198-466E-9997-7AFB5CFB808E

Q34173972-F1CD5856-C916-4032-8557-ED8EB3A89FF3

P304

Q34173972-7CFF48C0-E379-480A-B221-B63650226EA6

P31

Q34173972-6341B7B0-1EB0-412F-82C3-B2EF6A3B29E1

P356

Q34173972-ACC7C063-76CA-404C-90AF-1418A7F1FED1

P407

Q34173972-E1F1BCDE-088D-41F2-8336-581D95C1EEE1

P433

Q34173972-9E040198-3F68-4298-BB7A-E962F16B4B3E

P478

Q34173972-8C493870-BD31-4272-8530-03107AD67BF0

P577

Q34173972-3A7D8A76-81EC-4243-BA35-92C5FF1ED4D8

P698

Q34173972-58455E6F-350A-4F8B-97B1-1C69210EC670

P921

Q34173972-FE75C208-A8D6-4400-81F2-9FED80EA2335

P356

JCO.2010.29.2235

P1433

Journal of Clinical Oncology

P1476

Drug-related pneumonitis in pa ...... oma treated with temsirolimus.

@en

P2093

Anna Berkenblit

http://www.w3.org/2001/XMLSchema#string

Charles S White

http://www.w3.org/2001/XMLSchema#string

Gary Hudes

http://www.w3.org/2001/XMLSchema#string

Ignacio Duran

http://www.w3.org/2001/XMLSchema#string

Janice P Dutcher

http://www.w3.org/2001/XMLSchema#string

Jose Pablo Maroto

http://www.w3.org/2001/XMLSchema#string

Maria Cincotta

http://www.w3.org/2001/XMLSchema#string

Mark Shapiro

http://www.w3.org/2001/XMLSchema#string

Mizue Krygowski

http://www.w3.org/2001/XMLSchema#string

Theodore F Logan

http://www.w3.org/2001/XMLSchema#string

P304

1750-1756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.29.2235

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21444868

http://www.w3.org/2001/XMLSchema#string

P921